VOYA Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $611K | Sell |
|
|||||
|
2025
Q2 | $588K | Buy |
|
|||||
|
2025
Q1 | $499K | Sell |
|
|||||
|
2024
Q4 | $553K | Sell |
|
|||||
|
2024
Q3 | $556K | Sell |
|
|||||
|
2024
Q2 | $480K | Buy |
|
|||||
|
2024
Q1 | $411K | Sell |
|
|||||
|
2023
Q4 | $486K | Buy |
|
|||||
|
2023
Q3 | $403K | Buy |
|
|||||
|
2023
Q2 | $478K | Buy |
|
|||||
|
2023
Q1 | $426K | Hold |
|
|||||
|
2022
Q4 | $387K | Sell |
|
|||||
|
2022
Q3 | $498K | Hold |
|
|||||
|
2022
Q2 | $516K | Sell |
|
|||||
|
2022
Q1 | $675K | Buy |
|
|||||
|
2021
Q4 | $910K | Sell |
|
|||||
|
2021
Q3 | $1.28M | Sell |
|
|||||
|
2021
Q2 | $1.22M | Sell |
|
|||||
|
2021
Q1 | $1.48M | Buy |
|
|||||
|
2020
Q4 | $947K | Buy |
|
|||||
|
2020
Q3 | $756K | Buy |
|
|||||
|
2020
Q2 | $655K | Sell |
|
|||||
|
2020
Q1 | $629K | Sell |
|
|||||
|
2019
Q4 | $2.26M | Sell |
|
|||||
|
2019
Q3 | $4.88M | Sell |
|
|||||
|
2019
Q2 | $25.3M | Buy |
|
|||||
|
2019
Q1 | $26.2M | Buy |
|
|||||
|
2018
Q4 | $25.6M | Buy |
|
|||||
|
2018
Q3 | $40.8M | Buy |
|
|||||
|
2018
Q2 | $30.6M | Sell |
|
|||||
|
2018
Q1 | $24.4M | Buy |
|
|||||
|
2017
Q4 | $1.94M | Sell |
|
|||||
|
2017
Q3 | $1.95M | Sell |
|
|||||
|
2017
Q2 | $25.4M | Sell |
|
|||||
|
2017
Q1 | $22.6M | Buy |
|
|||||
|
2016
Q4 | $18.5M | Buy |
|
|||||
|
2016
Q3 | $17.9K | Buy |
|
|||||
|
2016
Q2 | $20.1M | Buy |
|
|||||
|
2016
Q1 | $1.25M | Buy |
|
|||||
|
2015
Q4 | $862K | Hold |
|
|||||
|
2015
Q3 | $681K | Sell |
|
|||||
|
2015
Q2 | $992K | Sell |
|
|||||
|
2015
Q1 | $953K | Sell |
|
|||||
|
2014
Q4 | $720K | Hold |
|
|||||
|
2014
Q3 | $635K | Hold |
|
|||||
|
2014
Q2 | $842K | Sell |
|
|||||
|
2014
Q1 | $977K | Hold |
|
|||||
|
2013
Q4 | $764K | Hold |
|
|||||
|
2013
Q3 | $629K | Hold |
|
|||||
|
2013
Q2 | $543K | Buy |
|